Potential factors affecting embryo survival and clinical outcome with cryopreserved pronuclear human embryos
- PMID: 15284794
- DOI: 10.1016/j.ajog.2004.02.049
Potential factors affecting embryo survival and clinical outcome with cryopreserved pronuclear human embryos
Abstract
Objective: This study was undertaken to determine whether the method of fertilization has a significant impact on survival and/or clinical pregnancy rates of cryopreserved human pronuclear (2PN) stage embryos.
Design: A retrospective analysis of cryosurvival and clinical pregnancy rates after thawing of 2PN stage embryos from January 2000 through December 2002 in a private Assisted Reproductive Technology (ART) center.
Material and methods: A total of 1408 human 2PN embryos were cryopreserved using a Planer Kryo 10 Series III freezing unit (TS Scientific, Perkasie, Pa) after dehydration/equilibration through Propanediol (Sigma Chemical, St. Louis, Mo) and sucrose. On thawing, embryos were cultured in vitro with P-1 medium with 10% Serum Substitute Supplement (Irvine Scientific, Santa Ana, Calif). Embryo transfer was performed at 40 to 48 hours from time of thaw into a recipient uterus after standard estradiol/progesterone preparation.
Results: In 2000, 78% of all frozen 2PN embryos survived and were transferred in 181 cycles producing a delivery rate of 26% per transfer. However, 59% of these cycles were intracytoplasmic sperm injection (ICSI), and the survival of frozen 2PN from these cycles (72%) was lower than the respective survival of frozen 2PN embryos from in vitro fertilization (IVF) (81%; P<.025). Changes to protocols for thawing frozen 2PN embryos were therefore explored and implemented during 2001, resulting in equivalent survival rates of frozen 2PN embryos from IVF and ICSI during 2001 (78% and 80%, respectively) and 2002 (73% and 74%, respectively). Coincidentally, the proportion of all cycles that were performed with ICSI increased (73% in 2001 to 78% in 2002; P<.01) and pregnancy rates after transfer of frozen/thawed 2PN embryos from ICSI increased from 15% in 2000 to 30% in 2002.
Conclusion: 2PN stage embryo cryosurvival may be negatively affected by ICSI, possibly caused by disruption of the zona pellucida and vitelline membrane before cryopreservation, and/or because ICSI promotes fertilization of some compromised eggs (producing compromised 2PN embryos) that would not have fertilized by conventional IVF. Without close attention to embryo freezing and thawing protocols relative to outcome, lower cryosurvival of unselected ICSI-produced embryos can negatively impact pregnancy outcomes.
Similar articles
-
A flexible protocol for cryopreservation of pronuclear and cleavage stage embryos created by conventional in vitro fertilization and intracytoplasmic sperm injection.Eur J Obstet Gynecol Reprod Biol. 2004 Dec 1;117(2):189-93. doi: 10.1016/j.ejogrb.2004.05.013. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15541856
-
Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome.Reprod Biomed Online. 2012 May;24(5):527-31. doi: 10.1016/j.rbmo.2012.02.001. Epub 2012 Feb 8. Reprod Biomed Online. 2012. PMID: 22480904
-
[Clinical effects of oocyte cryopreservation in assisted reproduction technology].Zhonghua Yi Xue Za Zhi. 2008 Oct 28;88(39):2755-8. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080449 Chinese.
-
An evaluation of embryo, zygote and oocyte cryopreservation in assisted reproductive technology.Afr J Med Med Sci. 2007 Dec;36(4):325-34. Afr J Med Med Sci. 2007. PMID: 18564648 Review.
-
Cryopreservation of embryos and oocytes: an update.Curr Opin Obstet Gynecol. 1993 Oct;5(5):606-14. Curr Opin Obstet Gynecol. 1993. PMID: 8241436 Review.
Cited by
-
Estimates of global research productivity in primary ovarian insufficiency from 2000 to 2021: Bibliometric analysis.Front Endocrinol (Lausanne). 2022 Oct 26;13:959905. doi: 10.3389/fendo.2022.959905. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387882 Free PMC article.
-
Current state and controversies in fertility preservation in women with breast cancer.World J Clin Oncol. 2017 Jun 10;8(3):241-248. doi: 10.5306/wjco.v8.i3.241. World J Clin Oncol. 2017. PMID: 28638793 Free PMC article. Review.
-
Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.J Clin Oncol. 2015 Aug 1;33(22):2424-9. doi: 10.1200/JCO.2014.59.3723. Epub 2015 Jun 22. J Clin Oncol. 2015. PMID: 26101247 Free PMC article.
-
Fertility preservation during cancer treatment: clinical guidelines.Cancer Manag Res. 2014 Mar 4;6:105-17. doi: 10.2147/CMAR.S32380. eCollection 2014. Cancer Manag Res. 2014. PMID: 24623991 Free PMC article. Review.
-
Fertility preservation in women with breast cancer.Clin Obstet Gynecol. 2010 Dec;53(4):753-62. doi: 10.1097/GRF.0b013e3181f96e00. Clin Obstet Gynecol. 2010. PMID: 21048442 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources